Expression of bone morphogenetic proteins and their receptors in the bone marrow megakaryocytes of GATA-1low mice: A possible role in osteosclerosis

Journal of Histochemistry and Cytochemistry

Volumn 55, Issue 7, 2007, Pages 745-752

  Garimella, Rama ^a   Kacena, Melissa A ^b   Tague, Sarah E ^a   Wang, Jinxi ^a   Horowitz, Mark C ^b   Anderson, H Clarke ^a,c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Bone morphogenetic proteins; GATA 1; Megakaryocytes; Myelofibrosis; Osteoblasts; Osteosclerosis

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; TRANSCRIPTION FACTOR GATA 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MEGAKARYOCYTE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WILD TYPE;

ANIMALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; CELL COUNT; FETUS; GATA1 TRANSCRIPTION FACTOR; IMMUNOHISTOCHEMISTRY; LIVER; MEGAKARYOCYTES; MICE; MICE, MUTANT STRAINS; OSTEOBLASTS; OSTEOCLASTS; OSTEOSCLEROSIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

MUS;

EID: 34250846433     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.6A7164.2007     Document Type: Article

References (44)

1. Ahmed N, Sammons J, Carson RJ, Khokher MA, Hassan HT (2001) Effect of bone morphogenetic protein-6 on haemopoietic stem cells and cytokine production in normal human bone marrow stroma. Cell Biol Int 25:429-435
2. Aubin JE (1999) Osteoprogenitor cell frequency in rat bone marrow stromal populations: role for heterotypic cell-cell interactions in osteoblast differentiation. J Cell Biochem 72:396-410
3. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, et al. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77:1117-1124
4. Beeton CA, Bord S, Ireland D, Compston JE (2006) Osteoclast formation and bone resorption are inhibited by megakaryocytes. Bone 39:985-990
5. Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE (2004) Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen. Br J Haematol 126:244-251
6. Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE (2005) Megakaryocytes modulate osteoblast synthesis of type-1 collagen, osteoprotegerin, and RANKL. Bone 36:812-819
7. Canalis E, Economides AN, Gazzerro E (2003) Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24:218-235
8. Chagraoui H, Tulliez M, Smayra T, Komura E, Giraudier S, Yun T, Lassau N, et al. (2003) Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. Blood 101:2983-2989
9. Chernoff A, Levine RF, Goodman DS (1980) Origin of platelet-derived growth factor in megakaryocytes in guinea pigs. J Clin Invest 65:926-930
10. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, et al. (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369: 533-538
11. Dhanyamraju R, Sipe J, Zhang J, Xu Y, Osdoby P, Insogna K, Anderson HC (2003) Localization of bone morphogenetic proteins (BMPs) in osteoclasts. Transactions of the 49th Annual Meeting of the Orthopaedic Research Society, New Orleans, LA
12. Drachman JG, Sabath DF, Fox NE, Kaushansky K (1997) Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 89:483-492
13. Fava RA, Casey TT, Wilcox J, Pelton RW, Moses HL, Nanney LB (1990) Synthesis of transforming growth factor-β1 by megakaryocytes and its localization to megakaryocyte and platelet α-granules. Blood 76:1946-1955
14. Friedman MS, Long MW, Hankenson KD (2006) Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J Cell Biochem 98:538-554
15. Garimella R, Tague SE, Zhang J, Anderson HC (2006) Expression and synthesis of bone morphogenetic proteins (BMPs) in osteoclast cultures. Transactions of the 52nd Annual Meeting of the Orthopedic Research Society, Chicago, IL
16. Gruber R, Kandler B, Fischer MB, Watzek G (2006) Osteogenic differentiation induced by bone morphogenetic proteins can be suppressed by platelet-released supernatant in vitro. Clin Oral Implants Res 17:188-193
17. Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer MB, Watzek G (2004) Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 15:29-35
18. Itoh S, Udagawa N, Takahashi N, Yoshitake F, Narita H, Ebisu S, Ishihara K (2006) A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone 39:505-512
19. Kacena MA, Gundberg CM, Horowitz MC (2006a) A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells. Bone 39:978-984
20. Kacena MA, Nelson T, Clough ME, Lee SK, Lorenzo JA, Gundberg CM, Horowitz MC (2006b) Megakaryocyte-mediated inhibition of osteoclast development. Bone 39:991-999
21. Kacena MA, Shivdasani RA, Wilson K, Xi Y, Troiano N, Nazarian A, Gundberg CM, et al. (2004) Megakaryocyte-osteoblast interaction revealed in mice deficient in transcription factors GATA-1 and NF-E2. J Bone Miner Res 19:652-660
22. Kark LR, Karp JM, Davies JE (2006) Platelet releasate increases the proliferation and migration of bone marrow-derived cells cultured under osteogenic conditions. Clin Oral Implants Res 17:321-327
23. T method. Methods 25:402-408
24. Martyre MC, Le Bousse-Kerdiles MC, Romquin N, Chevillard S, Praloran V, Demory JL, Dupriez B (1997) Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 97:441-448
25. McDevitt MA, Fujiwara Y, Shivdasani RA, Orkin SH (1997) An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice. Proc Natl Acad Sci USA 94: 7976-7981
26. Mohle R, Green D, Moore MA, Nachman RL, Rafii S (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 94:663-668
27. Nishimura T, Simmons DJ, Mainous EG (1997) The origin of bone formed by heterotopic periosteal autografts. J Oral Maxillofac Surg 55:1265-1268
28. Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, Kato M, Sampath TK, et al. (1998) Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 22:605-612
29. Reilly JT (1992) Pathogenesis of idiopathic myelofibrosis: role of growth factors. J Clin Pathol 45:461-464
30. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH (1997) A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J 16:3965-3973
31. Sipe JB, Zhang J, Waits C, Skikne B, Garimella R, Anderson HC (2004) Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets. Bone 35:1316-1322
32. Suda T, Takahashi N, Martin TJ (1992) Modulation of osteoclast differentiation. Endocr Rev 13:66-80
33. Tefferi A (2006) New insights into the pathogenesis and drug treatment of myelofibrosis. Curr Opin Hematol 13:87-92
34. Thiede MA, Smock SL, Petersen DN, Grasser WA, Thompson DD, Nishimoto SK (1994) Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology 135:929-937
35. Urist MR (1997) Bone morphogenetic protein: the molecularization of skeletal system development. J Bone Miner Res 12:343-346
36. low mice). Blood 100:1123-1132
37. Vannucchi AM, Bianchi L, Paoletti F, Pancrazzi A, Torre E, Nishikawa M, Zingariello M, et al. (2005) A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-β1 in the development of myelofibrosis. Blood 105:3493-3501
38. Villeval JL, Cohen-Solal K, Tulliez M, Giraudier S, Guichard J, Burstein SA, Cramer EM, et al. (1997) High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice. Blood 90:4369-4383
39. Vyas P, Ault K, Jackson CW, Orkin SH, Shivdasani RA (1999) Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 93:2867-2875
40. Wang X, Seed B (2003) A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31:e154
41. Wendling F, Maraskovsky E, Debili N, Florindo C, Teepe M, Titeux M, Methia N, et al. (1994) cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369:571-574
42. Wickenhauser C, Hillienhof A, Jungheim K, Lorenzen J, Ruskowski H, Hansmann ML, Thiele J, et al. (1995) Detection and quantification of transforming growth factor beta (TGF-beta) and platelet-derived growth factor (PDGF) release by normal human megakaryocytes. Leukemia 9:310-315
43. Wozney JM, Rosen V (1998) Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 346:26-37
44. Zeigler FC, de Sauvage F, Widmer HR, Keller GA, Donahue C, Schreiber RD, Malloy B, et al. (1994) In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood 84:4045-4052